Cashu | Summary

DJI

-0.55%

SPX

-0.69%

IXIC

-0.82%

FTSE

-0.87%

N225

-0.21%

AXJO

-0.51%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

-0.55%

SPX

-0.69%

IXIC

-0.82%

FTSE

-0.87%

N225

-0.21%

AXJO

-0.51%

HomeWatchlistNewsSignalsPicks

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Key Stats

Market Cap

6.79B

Dividend Yield

0.00%

P/E Ratio

-25.30

EPS

-3.04

Revenue

705.14M

Avg. Volume

1.70M

About

What does IONS do?

Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.

Sector

💻 Health Care

IPO

CEO

Employees

1,069

Headquarters

California, USA

Website

http://www.ionispharma.com